Skip to content
Home▶Archive▶Vol. 7 No. 2 (2024)▶Clinical Outcome of Vitamin D Supplementation in Moderate…
Academia Journal of Medicine
Print ISSN 2663-8282 · Online ISSN 2663-8290
Research Paper

Clinical Outcome of Vitamin D Supplementation in Moderate and Severe COVID-19 Patients: A Randomized Clinical Trial

, , , ,
Sanket Agrawal — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof& Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Sushant Meshram — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof& Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Shruti Agrawal — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof& Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Kamlesh Taori — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof& Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Shubham Biyani — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof& Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Published 30 Jul 2024 Vol. 7 No. 2 (2024), pp. 24-26 ● Open access
Formats:PDF ● Open access
Download PDF

Abstract

The COVID-19 pandemic has posed a major global health challenge, especially for individuals with underlying health issues. This study aimed to assess the clinical outcomes of vitamin D supplementation in patients with moderate to severe COVID-19 in a tertiary care hospital through a randomized clinical trial. Sixty-two SARS-CoV-2 positive patients were enrolled and divided into intervention (vitamin D supplementation) and control groups.

KeywordsCOVID-19Vitamin DSupplementationClinical OutcomesRandomized Clinical TrialTertiary Care HospitalInflammatory MarkersSteroid-Sparing Effect

The full text of this article is available as a PDF.

Download PDF
  1. World Health Organization. (n.d.). Coronavirus disease (COVID-
  2. 19) situation report. World Health Organization.
  3. Holick, M. F. (2007). Vitamin D deficiency. New England Journal
  4. of Medicine, 357(3), 266–281. https://doi.org/10.1056/
  5. NEJMra070553
  6. Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A.,
  7. French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence
  8. that vitamin D supplementation could reduce the risk of
  9. influenza and COVID-19 infections and deaths. Nutrients,
  10. 12(4), 988. https://doi.org/10.3390/nu12040988
  11. Dong, E., Du, H., & Gardner, L. (2020). An interactive webbased
  12. dashboard to track COVID-19 in real time. Lancet
  13. Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/
  14. S1473-3099(20)30120-1
  15. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu,
  16. Y., Wang, J., Liu, Y., Wei, Y., et al. (2020). Epidemiological
  17. and clinical characteristics of 99 cases of 2019 novel coronavirus
  18. pneumonia in Wuhan, China: A descriptive study.
  19. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/
  20. S0140-6736(20)30211-7
  21. Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang,
  22. H., Wang, Y., & Zhou, Y.-N. (2020). Prevalence of comorbidities
  23. and its effects in patients infected with SARS-CoV-2: A
  24. systematic review and meta-analysis. International Journal
  25. of Infectious Diseases, 94, 91–95. https://doi.org/10.1016/j.
  26. ijid.2020.03.017
  27. Shi, Y., Yu, X., Zhao, H., Wang, H., Zhao, R., & Sheng, J. (2020).
  28. Host susceptibility to severe COVID-19 and establishment
  29. of a host risk score: Findings of 487 cases outside Wuhan.
  30. Critical Care, 24(1), 1–4. https://doi.org/10.1186/s13054-
  31. 020-2833-7
  32. Mohan, M., Cherian, J. J., & Sharma, A. (2020). Exploring links
  33. between vitamin D deficiency and COVID-19. PLOS
  34. Pathogens. https://doi.org/10.1371/journal.ppat.1008874
  35. Alvarez-Rodriguez, L., Lopez-Hoyos, M., Garcia-Unzueta, M.,
  36. Amado, J. A., Cacho, P. M., & Martinez-Taboada, V. M.
  37. (2012). Age and low levels of circulating vitamin D are associated
  38. with impaired innate immune function. Journal of
  39. Leukocyte Biology, 91(5), 829–838. https://doi.org/10.1189/
  40. jlb.1011523

Looking up citing articles…